Search by Drug Name or NDC

    NDC 43063-0468-30 Lisinopril and Hydrochlorothiazide 25; 20 mg/1; mg/1 Details

    Lisinopril and Hydrochlorothiazide 25; 20 mg/1; mg/1

    Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

    Product Information

    NDC 43063-0468
    Product ID 43063-468_fa1b9aa0-5fb4-5420-e053-6394a90aebad
    Associated GPIs 36991802550320
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lisinopril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisinopril and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25; 20
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077912
    Listing Certified Through 2024-12-31

    Package

    NDC 43063-0468-30 (43063046830)

    NDC Package Code 43063-468-30
    Billing NDC 43063046830
    Package 30 TABLET in 1 BOTTLE, PLASTIC (43063-468-30)
    Marketing Start Date 2013-09-13
    NDC Exclude Flag N
    Pricing Information N/A